Amid increased concern over the growing epidemic of counterfeit drugs, the USA's National Association of Boards of Pharmacy has issued a warning concerning such worldwide activity, noting that much of it is aimed at US pharmacy outlets. According to a World Health Organization report last year, the current prevalence of counterfeit medicines can range to over 10% of the drug supply globally. The WHO also released figures which suggest that 50% of illegally-bought Internet-purchased drugs are fake and that the worst-affected regions of the world experience "over 30%" counterfeiting (Marketletter November 20, 2006).
The NABP noted that, in 2006 in the USA, 19 people were indicted in Detroit, Michigan, for importing and distributing counterfeit products, to include pharmaceuticals. A portion of the proceeds were used to fund the terrorist organization Hezbollah.
11 people in the states of Georgia, North Carolina and South Dakota and the Central American nation of Belize were indicted on charges of selling counterfeit prescription drugs over the Internet. Investigators believe many of the drugs had little or no medicinal value, and that those behind the scam netted over $19.0 million.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze